Billionaire Daniel Loeb Bets on Covid Vaccine Arriving this Year, Here’s What it Means for Your Equity Portfolios (FNLondon.com)
Billionaire hedge fund titan Daniel Loeb is prepping clients for a potential coronavirus vaccine as soon as the end of 2020. “We have spent significant time with scientific experts to better understand evolving treatments and vaccines, and have confidence that several will be effective and available later this year,” the hedge fund manager said in a 6 August investor letter seen by Financial News. Loeb said in the letter that a vaccine or medicine for Covid-19 “should lead to the next phase of market recovery in coronavirus‐affected companies.”
Allegedly Sexual Deviant Crispin Odey Definitely A Racist, Ghoul (Deal Breaker)
If you were a hedge fund manager facing serious allegations of sexual assault, you might think you’d have more important things to do than pontificating on matter macroeconomic to a journalist. Making plans for a decade in prison, perhaps, or ensuring that your deified chickens do not want from your absence. Then again, you probably also thought that Crispin Odey couldn’t do anything to make himself even more unlikeable.
15 Books Billionaire Investor Ray Dalio Says You should Read to Understand Today’s World and Lead a Fulfilling Life (Business Insider)
Billionaire investor Ray Dalio is known for his “principles” on everything from power dynamics to calling for “reform capitalism” in America. He authored a best-selling book, “Principles: Life and Work,” which elaborates on his core philosophies and the lessons throughout a more than 40-year career — from building the world’s largest hedge fund to now passing on what he’s learned. Dalio draws inspiration from more than just his own ruminations. He’s fond of reading and scouring through interviews, and he’s often vocal about turning to books for advice.
Pro VC Health Pulse: Point72 Targets Health-Care Startups; Biofourmis Raises $100 Million Financing Led by SoftBank; Covid Vaccine Watch (The Wall Street Journal)
Point72 Targets Health-Care Startups Good day. Point72 Ventures, the venture investment vehicle funded by billionaire hedge-fund manager Steven Cohen, is creating a new team that will deploy roughly $300 million into health-care startups over the next three years, according to Scott Barclay, who joined the firm to helm the effort.
Multi-Manager Hedge Fund Brummer in Positive Territory as Equities, Credit and Fixed Income Strategies Advance (Hedge Week)
Brummer & Partners, the Stockholm-based multi-strategy hedge fund firm, has seen its flagship vehicle advance further on the back of strong stock market gains in August, with equity, credit and fixed income funds all in positive territory. The Brummer Multi-Strategy (BMS) fund – which invests in a range of single-strategy hedge funds – made 0.4 per cent last month in its USD and SEK classes, bringing its year-to-date return to 4.2 per cent. The Brummer Multi-Strategy 2xL twice-levered version meanwhile rose 0.7 per cent in its SEK class and 0.8 per cent in its USD class in August, and is now up 7.3 per cent since the start of 2020.
Dollar General Corp (DG) CEO Todd J Vasos Sold $39.7 million of Shares (Guru Focus)
CEO of Dollar General Corp., Todd J Vasos, sold 198,000 shares of DG on 09/02/2020 at an average price of $200.28 a share. The total sale was $39.7 million. Dollar General Corp is a discount retailer in the United States. It offers a selection of merchandise, including consumables, seasonal, home products and apparel. Dollar General Corp has a market cap of $50.08 billion; its shares were traded at around $201.10 with a P/E ratio of 21.86 and P/S ratio of 1.63.
Thursday 9/3 Insider Buying Report: IVZ, BKR (Nasdaq.com)
At Invesco, a filing with the SEC revealed that on Wednesday, CEO Martin L. Flanagan purchased 294,507 shares of IVZ, for a cost of $10.19 each, for a total investment of $3M. So far Flanagan is in the green, up about 12.6% on their buy based on today’s trading high of $11.47. Invesco is trading up about 5% on the day Thursday. This buy marks the first one filed by Flanagan in the past twelve months. And at Baker Hughes, there was insider buying on Wednesday, by CEO Lorenzo Simonelli who bought 71,275 shares at a cost of $14.12 each, for a total investment of $1.01M. Before this latest buy, Simonelli bought BKR on 2 other occasions during the past twelve months, for a total cost of $499,195 at an average of $18.75 per share. Baker Hughes is trading up about 3.5% on the day Thursday. So far Simonelli is in the green, up about 5.2% on their purchase based on today’s trading high of $14.85.
The President-1-800-Flowers.com of 1-800 Flowers (NASDAQ: FLWS) is Selling Shares (Analyst Ratings)
Yesterday, the President-1-800-Flowers.com of 1-800 Flowers (FLWS), Thomas Hartnett, sold shares of FLWS for $1.27M. Following Thomas Hartnett’s last FLWS Sell transaction on November 29, 2016, the stock climbed by 20.5%. In addition to Thomas Hartnett, one other FLWS executive reported Sell trades in the last month.
Union Investment Trader on Leave Amid Insider-Trading Probe (1) (Bloomberg Law)
Union Investment Privatfonds GmbH said it put one of its employees on leave after regulators raided the Frankfurt-based company for evidence of insider-trading. The unidentified person is suspected of making a “significant amount” by trading securities on private accounts, Union Investment said in a statement Thursday. “Because of the seriousness of the allegations, this procedure is advisable, even if the presumption of innocence applies,” it said.
Grubhub Inc (GRUB) CEO Matthew M. Maloney Sold $10.9 million of Shares (Guru Focus)
CEO of Grubhub Inc, Matthew M. Maloney, sold 150,299 shares of GRUB on 08/31/2020 at an average price of $72.8 a share. The total sale was $10.9 million. GrubHub Inc is the online and mobile platform for restaurant pick-up and delivery orders. The company provides restaurants with more orders, helps to serve diners better and facilitates delivery logistics in many markets.